56 related articles for article (PubMed ID: 1284750)
21. Antibody response to hepatitis C virus infection after liver transplantation.
Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
[TBL] [Abstract][Full Text] [Related]
22. [Seroprevalence of hepatitis C virus in hemophiliacs in Switzerland].
Perret BA; Senn M; Affentranger P; Poorbeik M; Burckhardt JJ; Morell A
Schweiz Med Wochenschr; 1993 Jan; 123(3):79-81. PubMed ID: 7678942
[TBL] [Abstract][Full Text] [Related]
23. [Determination of hepatitis C antibodies, using the Abbott and the Ortho anti-HCV EIA kits, in chronic liver diseases and patients under hemodialysis for chronic renal failure].
Németh J; Héjjas M; Büki B; Takács M; Schaff Z; Makó J; Szalay F
Orv Hetil; 1992 Jul; 133 Suppl 1():24-7. PubMed ID: 1630801
[TBL] [Abstract][Full Text] [Related]
24. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to a novel antigen in acute hepatitis C virus infections.
Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
[TBL] [Abstract][Full Text] [Related]
26. [Hepatitis C antibodies in non-A, non-B hepatitis patients and members of HIV risk groups (pilot study)].
Kühnl P; Roggendorf M; Stangel W; Seidl S; Laufs R; Sibrowski W; Bornhövd K; Polywka S; Kalmar G; Deinhardt F
Beitr Infusionsther; 1990; 26():30-2. PubMed ID: 1703858
[TBL] [Abstract][Full Text] [Related]
27. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
28. A critical evaluation of hepatitis C testing of cadaveric corneal donors.
Laycock KA; Essary LR; Delaney S; Kuhns MC; Pepose JS
Cornea; 1997 Mar; 16(2):146-50. PubMed ID: 9071526
[TBL] [Abstract][Full Text] [Related]
29. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
30. [Antibodies against hepatitis C virus. Experience with a second generation test].
Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
G E N; 1991; 45(3):183-9. PubMed ID: 1726913
[TBL] [Abstract][Full Text] [Related]
31. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
Chaudhary RK; Maclean C
Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
[TBL] [Abstract][Full Text] [Related]
32. Improved detection of antibodies to hepatitis C virus in dialysis patients using a second-generation enzyme immunoassay.
de Medina M; Ortiz C; Krenc C; Leete J; Vallari D; Hill M; LaRue S; Jimenez M; Anderson W; Schiff E
Am J Kidney Dis; 1992 Dec; 20(6):589-91. PubMed ID: 1334368
[TBL] [Abstract][Full Text] [Related]
33. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation.
Teo CG; Gabriel FG; Mortimer PP
J Clin Pathol; 1992 Oct; 45(10):917-20. PubMed ID: 1331199
[TBL] [Abstract][Full Text] [Related]
34. A comparison of two supplemental procedures for confirmation of antibody to hepatitis C virus c100-3 antigen in Louisiana blood donors.
Smith D; Delaney S; Allain JP; Vallari D; Lee H
Transfusion; 1992 Jun; 32(5):415-9. PubMed ID: 1626344
[TBL] [Abstract][Full Text] [Related]
35. [Occurrence of antibodies against hepatitis C virus (HCV) among alcoholics].
Laskus T; Radkowski M; Lupa E; Halama G; Nowicka R; Cianciara J; Slusarczyk J
Pol Arch Med Wewn; 1992 Jan; 87(1):1-7. PubMed ID: 1322534
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of first- and second-generation assays for detection of antibody to hepatitis C virus in non-A, non-B chronic liver diseases--evaluation of 1st and 2nd-generation assays in NANBH.
Tokeshi S; Sata M; Hino T; Ide T; Noguchi S; Suzuki H; Muraoka H; Nakano H; Tanikawa K
Kurume Med J; 1993; 40(1):27-32. PubMed ID: 7689126
[TBL] [Abstract][Full Text] [Related]
37. Discrepant results of different tests for antibodies to hepatitis C in children with malignant diseases and in patients on renal replacement therapy.
Rautenberg P; Schneppenheim R; Leimenstoll G; Behnke H; Loose G
Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):978-81. PubMed ID: 1724423
[TBL] [Abstract][Full Text] [Related]
38. Peptide based enzyme immunoassays for detecting hepatitis C antibodies in sera of people at high risk.
Gabriel FG; Teo CG
J Clin Pathol; 1994 Apr; 47(4):357-9. PubMed ID: 8027376
[TBL] [Abstract][Full Text] [Related]
39. Comparison of two approved enzyme immunoassays for the detection of antibodies to the hepatitis C virus in 5216 United States blood donors.
Betlach B; Anderson S; Rodriguez R; Kuramoto K; Sazama K; Holland PV
Transfusion; 1992 Feb; 32(2):191-2. PubMed ID: 1371896
[No Abstract] [Full Text] [Related]
40. Prevalence of non-A,non-B hepatitis/hepatitis C virus antibody in human immunoglobulins.
Dodd LG; McBride JH; Gitnick GL; Howanitz PJ; Rodgerson DO
Am J Clin Pathol; 1992 Jan; 97(1):108-13. PubMed ID: 1728850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
